Centenary Institute
Grant
A new therapy for Pancreatic Cancer that improves tumour microenvironment and immune cell penetration
Award
2015 Accelerator Grant
Institution
University of Sydney, Centenary Institute
The two major influences on the outcome of Pancreatic Cancer are the individual genetic changes in the cancer and the submissive tumour microenvironment. This application lays the groundwork for a new drug that favourably alters the tumour microenvironment. The drug should be useful for ALL patients regardless of the state of progression of the disease. This will be a major breakthrough in disease treatment.
Professor Jennifer Gamble and Professor Mathew Vadas, AO
Research Reports
Click to download progress reporting on the outcomes of this research.